DRIVE – Development of Robust and Innovative Vaccine Effectiveness
Increasing understanding of influenza vaccine effectiveness in Europe
Click here to watch a short video summarising the DRIVE project objectives and achievements through its 5 years of life.
The project officially ended under IMI funding in July 2022, although the website will continue to be active to host several project activities still ongoing under a post-DRIVE Memorandum of Understanding (MoU). These include the coordination and evaluation of secondary use of data inquiries and the publication of project derived results.
DRIVE is a public private partnership that advances European cooperation in influenza vaccine effectiveness studies. It seeks to establish a sufficiently sized network for robust, high quality, brand-specific effectiveness estimates for all influenza vaccines used in the EU each season. The data generated through DRIVE is expected to increase the understanding of influenza vaccine effectiveness, lead to enhanced monitoring of influenza vaccine performance by public health institutes and allow manufacturers to fulfil regulatory requirements. DRIVE also aims to develop a sustainable and transparent governance model for public private partnerships.